ERBB2 and glioblastoma: Further, Ahmed et al. reported that HER2-redirected CAR T cells specific for the CMV.pp65 antigen reduced tumor volume and was clinically beneficial in 33% of GBM patients [48], and Shiina et al. reported that podoplanin-targeting CAR-T cells inhibited orthotopic GBM in a mouse brain model [49].